Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.
Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A, Morecki S, Andolfi G, Tabucchi A, Carlucci F, Marinello E, Cattaneo F, Vai S, Servida P, Miniero R, Roncarolo MG, Bordignon C.
Aiuti A, et al.
Science. 2002 Jun 28;296(5577):2410-3. doi: 10.1126/science.1070104.
Science. 2002.
PMID: 12089448
Clinical Trial.